Richa Manwani, MD^1*, Amit Bhattacharyya, PhD^2*, Michelle Dawson, PhD^3* and Nina Shah, MD⁴

¹Alexion, AstraZeneca Rare Disease, London, United Kingdom
²Alexion, AstraZeneca Rare Disease, Wilmington
³AstraZeneca, Gaithersburg
⁴AstraZeneca, South San Francisco, CA

Esther Natalie Oliva, MD^1,2,3,4, Fabio Efficace, PhD^5*, Maria Rosa Valvano^6*, Paola Arcuri^7*, Roberta Battistini^8*, Elisa Buzzatti^9*, Cristina Clissa, MD^10*, Cristina Danesin^11*, Alessia Salemme^12*, Francesco Sparano^5* and Federico Chiurazzi^13*

¹Hematology Unit, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
²U.O.C. Ematologia, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
³Hematology Unit, Grande Ospedale Metropolitano BMM, Reggio Calabria, Reggio Calabria, Italy
⁴Grande Ospedale Metropolitano BMM, Reggio Calabria, Reggio Calabria, ITA
⁵Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA), Rome, Italy
⁶UOS Qualità e Accreditamento, IRCCS "Casa Sollievo della Sofferenza", Hospital, San Giovanni Rotondo, Italy
⁷Hematology Section, Department of Radiological and Hematological Sciences, Catholic University of Sacred Heart, Rome, Italy
⁸Hematology and Hematopoietic Stem Cells Transplant Unit, Ospedale San Camillo Forlanini, Rome, Italy
⁹Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
¹⁰Hematology Unit, AOU Integrata Di Verona, Policlinico G.B. Rossi, Verona, Italy
¹¹Hematology Unit, Ospedale Ca’ Foncello, Treviso, Italy
¹²Hematology Unit, AOU-Federico II, Naples, Naples, ITA
¹³Freelance, Naples, Italy

Patrick Ansah^1*, Bharat Parmar^2*, Dickens Onyango^3*, Peter Mogere^4*, Nicola Lister^5*, Barun Rai^6*, Kwaku Marfo^7* and Dipty Lalit Jain, MD, MBBS⁸

¹Navrongo Health Research Centre, Ghana Health Service, Ghana, Navrongo, Ghana
²Zydus Medical College and Hospital Civil Hospital, Dahod, India
³Clinical Research Health Network (CREA-N), Nairobi, Kenya
⁴Novartis Kenya Limited, Nairobi, Kenya
⁵Novartis Pharma AG, Basel, Switzerland
⁶Novartis Healthcare Pvt. Ltd., Hyderabad, India
⁷Novartis Pharmaceuticals Corporation, New Jersey
⁸Arihant Multi-speciality hospital, Nagpur, India

Max Jordan Nguemeni Tiako, MD, MS^1*, Jennifer A. Afranie-Sakyi, MD², Layla N Van Doren, MD, MBA³, Kimberly S. Vasquez, MPH^4* and Cecelia Calhoun, MD, MBA, MPH²

¹General Medicine & Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA
²Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
³Section of Hematology, Division of Medicine, Yale School of Medicine, New Haven, CT
⁴Yale University School of Medicine, New Haven, CT

Vishwanath Anil^1*, Raag Patel^2*, Chakravarthy Nulu^2*, Rohan Vuppala^2*, Malek Moumne^2*, Daylen Lomeli^3*, Samantha Cye^3*, Brooke Coates^3*, William Long^2*, Amany R. Keruakous⁴ and Danny Yakoub^2*

¹Wellstar Spalding Medical Center, Griffin, GA
²Medical College of Georgia, Augusta, GA
³University of Georgia, Athens, GA
⁴Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA

S Christy Rohani-Montez, PhD^1*, Michelle Arielle Worst, MBA, PharmD^2*, Stephanie Baumhover^3*, Alyssa Mitarotondo^3*, Emily Mikhael, MS^2*, Sigbjørn Berentsen^4* and Roy Smith⁵

¹Medscape Education Global, London, United Kingdom
²Medscape, LLC, New York, NY
³Medscape Education, New York
⁴Haugesund Hospital, Haugesund, NOR
⁵Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA

Michelle Arielle Worst, MBA, PharmD^1*, Heather P. Friedman, MPH^2*, Sarah E. Bomba, PharmD, BCOP^2*, Megan Whitney, DMD^2*, Davecia Cameron, MS^2*, Deborah Middleton, MS^2*, Charlotte Warren, MA^2*, Haleh Kadkhoda, MS^2* and Nikolai A. Podoltsev, MD, PhD³

¹Medscape, LLC, New York, NY
²Medscape, LLC, Newark, NJ
³Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT

Victoria Harvey-Jones^1*, Sarah E. Bomba, PharmD, BCOP^2*, Sanneke Koekkoek^3*, Ahmad Sarris^4*, Haleh Kadkhoda, MS^2*, Lauren Berger, MPH^5* and Jennifer A. Woyach, MD⁶

¹Medscape Education Global, Milton Keynes, ENG, United Kingdom
²Medscape, LLC, Newark, NJ
³Medscape Education Global, Atlanta, GA
⁴Medscape, LLC, Newark
⁵Leukemia & Lymphoma Society, Rye Brook, NY
⁶Division of Hematology, Ohio State University Comprehensive Cancer Center, Columbus, OH

Carmine Deluca^1*, Nicholas J. Short, MD², Michael Beyer, BS^3*, Andrea Corti, PhD^4* and Jessica Massey, MD^3*

¹PeerView Institute for Medical Education, Silver Spring, MD
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³PeerView Institute for Medical Education, New York, NY
⁴PVI, PeerView Institute for Medical Education, Inc., New York, NY

Andres Noyola-Perez, MD¹, Alexia Sánchez^2*, Ana Laura Varela Constantino, MD^3*, Elías Eugenio Gonzalez-López, MD^4*, Anna C Rodriguez^5*, Fernando J Medina-Olivares^6*, Sergio U. Villegas, MD^7*, David Gomez-De Leon^8*, Rahul Gosain^9* and Andres Gomez-De Leon, MD¹⁰

¹Hematology Department, Universidad Autonoma de Nuevo Leon (UANL). Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Monterrey, Mexico
²Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico
³Tec Salud, Instituto Tecnológico de Estudios Superiores de Monterrey, Monterrey, NL, Mexico
⁴Clínica Gómez-Almaguer, Monterrey, NL, Mexico
⁵Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Servicio de Hematología, Mexico, Monterrey, AG, Mexico
⁶Universidad Autonoma de Nuevo Leon, Monterrey, NL, Mexico
⁷Internal Medicine, Baylor College of Medicine, Dallas, TX
⁸MedBy Org, Monterrey, Mexico
⁹University of Rochester Medical Center, Rochester, MN
¹⁰Hematology, Universidad Autónoma de Nuevo León, Facultad de Medicina y Hospital Universitario Dr José Eleuterio González, Monterrey, Mexico